Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C M Rudin

Showing results (21-30 of 44) with videos related to

Pageof 5
Sort By:
The Journal of Experimental Medicine|June 1, 1989
Inhibition of immunoglobulin gene rearrangement by the expression of a lambda 2 transgeneJ Hagman, D Lo, L T Doglio, et al.
Oncogene|February 3, 2000
Cell line dependence of Bcl-2-induced alteration of glutathione handlingN F Schor, C M Rudin, A R Hartman, et al.
Oncogene|March 10, 2015
DNA methylation in small cell lung cancer defines distinct disease subtypes and correlates with high expression of EZH2J T Poirier, E E Gardner, N Connis, et al.
Clinical Lung Cancer|January 21, 2004
A phase I study of STEALTH cisplatin (SPI-77) and vinorelbine in patients with advanced non small-cell lung cancerE E Vokes, G S Gordon, A M Mauer, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|August 26, 1999
Early release of mitochondrial cytochrome c and expression of mitochondrial epitope 7A6 with a porphyrin-derived photosensitizer: Bcl-2 and Bcl-xL overexpression do not prevent early mitochondrial events but still depress caspase activityC M Carthy, D J Granville, H Jiang, et al.
Investigational New Drugs|September 20, 2001
A phase I trial of the oral platinum analogue JM216 with concomitant radiotherapy in advanced malignancies of the chestC M George, D J Haraf, A M Mauer, et al.
Investigational New Drugs|September 20, 2001
A phase II trial of 9-aminocaptothecin (9-AC) as a 120-h infusion in patients with non-small cell lung cancerE E Vokes, G S Gordon, C M Rudin, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 12, 2002
A pilot trial of G3139, a bcl-2 antisense oligonucleotide, and paclitaxel in patients with chemorefractory small-cell lung cancerC M Rudin, G A Otterson, A M Mauer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 12, 2017
Phase 1 study of twice weekly pulse dose and daily low-dose erlotinib as initial treatment for patients with EGFR-mutant lung cancersH A Yu, C Sima, D Feldman, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 21, 2004
A phase II study of oxaliplatin and paclitaxel in patients with advanced non-small-cell lung cancerJ D Winegarden, A M Mauer, G A Otterson, et al.
Pageof 5

Showing results (21-30 of 44) with videos related to

Sort By:
Pageof 5
The Journal of Experimental Medicine|June 1, 1989
Inhibition of immunoglobulin gene rearrangement by the expression of a lambda 2 transgeneJ Hagman, D Lo, L T Doglio, et al.
Oncogene|February 3, 2000
Cell line dependence of Bcl-2-induced alteration of glutathione handlingN F Schor, C M Rudin, A R Hartman, et al.
Oncogene|March 10, 2015
DNA methylation in small cell lung cancer defines distinct disease subtypes and correlates with high expression of EZH2J T Poirier, E E Gardner, N Connis, et al.
Clinical Lung Cancer|January 21, 2004
A phase I study of STEALTH cisplatin (SPI-77) and vinorelbine in patients with advanced non small-cell lung cancerE E Vokes, G S Gordon, A M Mauer, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|August 26, 1999
Early release of mitochondrial cytochrome c and expression of mitochondrial epitope 7A6 with a porphyrin-derived photosensitizer: Bcl-2 and Bcl-xL overexpression do not prevent early mitochondrial events but still depress caspase activityC M Carthy, D J Granville, H Jiang, et al.
Investigational New Drugs|September 20, 2001
A phase I trial of the oral platinum analogue JM216 with concomitant radiotherapy in advanced malignancies of the chestC M George, D J Haraf, A M Mauer, et al.
Investigational New Drugs|September 20, 2001
A phase II trial of 9-aminocaptothecin (9-AC) as a 120-h infusion in patients with non-small cell lung cancerE E Vokes, G S Gordon, C M Rudin, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 12, 2002
A pilot trial of G3139, a bcl-2 antisense oligonucleotide, and paclitaxel in patients with chemorefractory small-cell lung cancerC M Rudin, G A Otterson, A M Mauer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 12, 2017
Phase 1 study of twice weekly pulse dose and daily low-dose erlotinib as initial treatment for patients with EGFR-mutant lung cancersH A Yu, C Sima, D Feldman, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 21, 2004
A phase II study of oxaliplatin and paclitaxel in patients with advanced non-small-cell lung cancerJ D Winegarden, A M Mauer, G A Otterson, et al.
Pageof 5